NeuroOne Medical Technologies Corporation
NMTC
$0.652
$0.04858.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.79M | -3.35M | -2.77M | -2.86M | -3.34M |
| Total Depreciation and Amortization | 65.10K | 64.10K | 63.10K | 60.90K | 58.70K |
| Total Amortization of Deferred Charges | 192.60K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 109.40K | 923.40K | 366.90K | 386.30K | 337.50K |
| Change in Net Operating Assets | -1.94M | -303.80K | -22.90K | 232.70K | -860.60K |
| Cash from Operations | 208.00K | -2.67M | -2.36M | -2.18M | -3.81M |
| Capital Expenditure | -24.40K | -36.90K | -14.80K | -31.40K | -37.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -24.40K | -36.90K | -14.80K | -31.40K | -37.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 836.80K | 1.68M | 2.09M | 1.26M |
| Repurchase of Common Stock | -11.30K | -9.80K | -46.70K | -11.30K | -13.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -498.10K | 1.72M | -76.20K | -122.70K | -37.70K |
| Cash from Financing | -509.30K | 2.54M | 1.56M | 1.96M | 1.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -325.70K | -159.90K | -814.70K | -246.30K | -2.64M |